-
Product Insights
Topa Mine
The Topa Mine is a coal mine in India. It is currently in operation. Empower your strategies with our Topa Mine report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Reasons to buy Gain vital information...
-
Product Insights
Pemphigus Vulgaris – Drugs In Development, 2023
Global Markets Direct’s, ‘Pemphigus Vulgaris - Drugs In Development, 2023’, provides an overview of the Pemphigus Vulgaris pipeline landscape. The report provides comprehensive information on the therapeutics under development for Pemphigus Vulgaris, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an...
-
Product Insights
Pemphigus – Drugs In Development, 2023
Global Markets Direct’s, ‘Pemphigus - Drugs In Development, 2023’, provides an overview of the Pemphigus pipeline landscape. The report provides comprehensive information on the therapeutics under development for Pemphigus, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key...
-
Product Insights
Celiac Disease – Drugs In Development, 2023
Global Markets Direct’s, ‘Celiac Disease - Drugs In Development, 2023’, provides an overview of the Celiac Disease pipeline landscape. The report provides comprehensive information on the therapeutics under development for Celiac Disease, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an...
-
Product Insights
Cholangitis – Drugs In Development, 2023
Global Markets Direct’s, ‘Cholangitis - Drugs In Development, 2023’, provides an overview of the Cholangitis pipeline landscape. The report provides comprehensive information on the therapeutics under development for Cholangitis, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key...
-
Product Insights
Uveitis – Drugs In Development, 2023
Global Markets Direct’s, ‘Uveitis - Drugs In Development, 2023’, provides an overview of the Uveitis pipeline landscape. The report provides comprehensive information on the therapeutics under development for Uveitis, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – TPM-203 in Pemphigus Vulgaris
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - TPM-203 in Pemphigus Vulgaris report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.TPM-203 in Pemphigus Vulgaris Drug Details: TPM203 is under development for the treatment...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – LTP-001 in Idiopathic Pulmonary Fibrosis
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - LTP-001 in Idiopathic Pulmonary Fibrosis report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. LTP-001 in Idiopathic Pulmonary Fibrosis Drug Details: LTP-001 is under development...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – TPM-502 in Celiac Disease
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data.TPM-502 in Celiac DiseaseDrug Details:TPM-502 is under development for the treatment of celiac disease. The therapeutic...
-
Sector Analysis
United Kingdom Meat Substitutes Market Opportunities, Trends, Growth Analysis and Forecast to 2027
UK Meat Substitutes Market Overview The UK meat substitutes market was valued at GBP 623 million ($770.8 million) in 2022 and is expected to grow at a CAGR of more than 5% during the period 2022-2027. Single cell protein (Fungi/Algae) was the largest category in volume terms in 2022. The category is also forecast to register the fastest volume growth during 2022–2027, followed by soy based and vegetable/plant-based proteins. UK Meat Substitutes Market Outlook, (GBP Million, 2022) For more insights...